ITGAX and Langerhans cell histiocytosis: A mouse LCH model using a BRAF V600E construct under control of the CD11c promoter and a BRAF V600E construct under control of the langerin promoter indicates that the BRAF V600E is not only a marker but also an essential driver of LCH pathogenesis [102].